LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis.

    Silver, Bronwyn J / Guy, Rebecca J / Kaldor, John M / Jamil, Muhammad S / Rumbold, Alice R

    Sexually transmitted diseases

    2014  Volume 41, Issue 6, Page(s) 369–376

    Abstract: Trichomonas vaginalis is the most common curable sexually transmissible infection worldwide, with high rates in women of reproductive age. There have been inconsistent findings about the impact of infection and its treatment in pregnancy. We conducted a ... ...

    Abstract Trichomonas vaginalis is the most common curable sexually transmissible infection worldwide, with high rates in women of reproductive age. There have been inconsistent findings about the impact of infection and its treatment in pregnancy. We conducted a meta-analysis to determine the association between T. vaginalis and perinatal outcomes. Electronic databases were searched to May 2013. Included studies reported perinatal outcomes in women infected and uninfected with T. vaginalis. Meta-analysis calculated a pooled relative risk (RR) and 95% confidence interval (CI) using either a fixed- or random-effects model. Study bias was assessed using funnel plots. Of 178 articles identified, 11 studies met the inclusion criteria. The study populations, outcomes, and quality varied. T. vaginalis in pregnancy was associated with an increased risk of preterm birth (RR, 1.42; 95% CI, 1.15-1.75; 9 studies; n = 81,101; I = 62.7%), preterm premature rupture of membranes (RR, 1.41; 95% CI,1.10-1.82; 2 studies; n = 14,843; I = 0.0%) and small for gestational age infants (RR, 1.51; 95% CI,1.32-1.73; 2 studies; n = 14,843; I = 0.0%). Sensitivity analyses of studies that accounted for coinfection with other sexually transmissible infection found a slightly reduced RR of 1.34 for preterm birth (95% CI, 1.19-1.51; 6 studies; n = 72,077; I = 11.2%), and in studies where no treatment was confirmed, the RR was 1.83 (95% CI, 0.98-3.41; 3 studies; n = 1795; I = 22.3%). Our review provides strong evidence that T. vaginalis in pregnancy is associated with an increased risk of preterm birth. Based on fewer studies, there were also substantial increases in the risk of preterm premature rupture of membranes and small for gestational age infants. Further studies that address the current gaps in evidence on treatment effects in pregnancy are needed.
    MeSH term(s) Adult ; Female ; Fetal Membranes, Premature Rupture/etiology ; Humans ; Infant, Newborn ; Infant, Small for Gestational Age ; Pregnancy ; Pregnancy Complications, Infectious/etiology ; Pregnancy Complications, Infectious/prevention & control ; Premature Birth/etiology ; Risk ; Trichomonas Vaginitis/complications ; Trichomonas Vaginitis/prevention & control ; Trichomonas vaginalis/pathogenicity
    Language English
    Publishing date 2014-06
    Publishing country United States
    Document type Journal Article ; Meta-Analysis ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 435191-5
    ISSN 1537-4521 ; 0148-5717
    ISSN (online) 1537-4521
    ISSN 0148-5717
    DOI 10.1097/OLQ.0000000000000134
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Strategies to improve control of sexually transmissible infections in remote Australian Aboriginal communities: a stepped-wedge, cluster-randomised trial.

    Ward, James / Guy, Rebecca J / Rumbold, Alice R / McGregor, Skye / Wand, Handan / McManus, Hamish / Dyda, Amalie / Garton, Linda / Hengel, Belinda / Silver, Bronwyn J / Taylor-Thomson, Debbie / Knox, Janet / Donovan, Basil / Law, Matthew / Maher, Lisa / Fairley, Christopher K / Skov, Steven / Ryder, Nathan / Moore, Elizabeth /
    Mein, Jacqueline / Reeve, Carole / Ah Chee, Donna / Boffa, John / Kaldor, John M

    The Lancet. Global health

    2019  Volume 7, Issue 11, Page(s) e1553–e1563

    Abstract: Background: Remote Australian Aboriginal communities have among the highest diagnosed rates of sexually transmissible infections (STIs) in the world. We did a trial to assess whether continuous improvement strategies related to sexual health could ... ...

    Abstract Background: Remote Australian Aboriginal communities have among the highest diagnosed rates of sexually transmissible infections (STIs) in the world. We did a trial to assess whether continuous improvement strategies related to sexual health could reduce infection rates.
    Methods: In this stepped-wedge, cluster-randomised trial (STIs in remote communities: improved and enhanced primary health care [STRIVE]), we recruited primary health-care centres serving Aboriginal communities in remote areas of Australia. Communities were eligible to participate if they were classified as very remote, had a population predominantly of Aboriginal people, and only had one primary health-care centre serving the population. The health-care centres were grouped into clusters on the basis of geographical proximity to each other, population size, and Aboriginal cultural ties including language connections. Clusters were randomly assigned into three blocks (year 1, year 2, and year 3 clusters) using a computer-generated randomisation algorithm, with minimisation to balance geographical region, population size, and baseline STI testing level. Each year for 3 years, one block of clusters was transitioned into the intervention phase, while those not transitioned continued usual care (control clusters). The intervention phase comprised cycles of reviewing clinical data and modifying systems to support improved STI clinical practice. All investigators and participants were unmasked to the intervention. Primary endpoints were community prevalence and testing coverage in residents aged 16-34 years for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis. We used Poisson regression analyses on the final dataset and compared STI prevalences and testing coverage between control and intervention clusters. All analyses were by intention to treat and models were adjusted for time as an independent covariate in overall analyses. This study was registered with the Australia and New Zealand Clinical Trials Registry, ACTRN12610000358044.
    Findings: Between April, 2010, and April, 2011, we recruited 68 primary care centres and grouped them into 24 clusters, which were randomly assigned into year 1 clusters (estimated population aged 16-34 years, n=11 286), year 2 clusters (n=10 288), or year 3 clusters (n=13 304). One primary health-care centre withdrew from the study due to restricted capacity to participate. We detected no difference in the relative prevalence of STIs between intervention and control clusters (adjusted relative risk [RR] 0·97, 95% CI 0·84-1·12; p=0·66). However, testing coverage was substantially higher in intervention clusters (22%) than in control clusters (16%; RR 1·38; 95% CI 1·15-1·65; p=0·0006).
    Interpretation: Our intervention increased STI testing coverage but did not have an effect on prevalence. Additional interventions that will provide increased access to both testing and treatment are required to reduce persistently high prevalences of STIs in remote communities.
    Funding: Australian National Health and Medical Research Council.
    MeSH term(s) Adolescent ; Adult ; Australia ; Chlamydia Infections/prevention & control ; Female ; Health Services, Indigenous/organization & administration ; Humans ; Male ; Middle Aged ; Oceanic Ancestry Group/statistics & numerical data ; Prevalence ; Primary Health Care/organization & administration ; Rural Population/statistics & numerical data ; Sexually Transmitted Diseases/prevention & control ; Trichomonas Infections/prevention & control ; Young Adult
    Language English
    Publishing date 2019-10-13
    Publishing country England
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 2723488-5
    ISSN 2214-109X ; 2214-109X
    ISSN (online) 2214-109X
    ISSN 2214-109X
    DOI 10.1016/S2214-109X(19)30411-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Frequent occurrence of undiagnosed pelvic inflammatory disease in remote communities of central Australia.

    Silver, Bronwyn J / Knox, Janet / Smith, Kirsty S / Ward, James S / Boyle, Jacqueline / Guy, Rebecca J / Kaldor, John / Rumbold, Alice R

    The Medical journal of Australia

    2011  Volume 197, Issue 11, Page(s) 647–651

    Abstract: Objective: To assess the extent of diagnosed and undiagnosed pelvic inflammatory disease (PID) in Aboriginal women in remote central Australia.: Design, setting and subjects: Retrospective cross-sectional study in five remote central Australian ... ...

    Abstract Objective: To assess the extent of diagnosed and undiagnosed pelvic inflammatory disease (PID) in Aboriginal women in remote central Australia.
    Design, setting and subjects: Retrospective cross-sectional study in five remote central Australian primary health care centres. Medical records of all resident Aboriginal women aged 14-34 years were examined. Data were from presentations with documented lower abdominal pain, excluding other causes, for 2007-2008.
    Main outcome measures: PID investigations undertaken, PID diagnoses made, recommended treatment, and presentations meeting the guideline criteria for diagnosing PID based on pelvic examination, symptom profile or history.
    Results: Of 655 medical records reviewed, 119 women (18%) presented 224 times with lower abdominal pain. Recommended investigations to diagnose PID were infrequently undertaken: bimanual examination (15 cases [7%]); testing for gonorrhoea and chlamydia (78 [35%]); and history taking for vaginal discharge (59 [26%]), intermenstrual bleeding (27 [12%]) and dyspareunia (17 [8%]). There were 95 presentations (42%) consistent with guidelines to diagnose PID, most (87 [39%]) based on symptom profile and history. Of these, practitioners made 15 diagnoses of PID, and none had the recommended treatment documented.
    Conclusion: Pelvic inflammatory disease occurred frequently among Aboriginal women in central Australia during the study period but was vastly underdiagnosed and poorly treated. Undiagnosed or inadequately treated PID leads to poorer reproductive health outcomes in the long term. Increased awareness of PID symptoms, diagnosis and treatment and a revision of the guidelines is needed to improve detection and management of PID in this high-risk setting.
    MeSH term(s) Adolescent ; Adult ; Australia/epidemiology ; Cross-Sectional Studies ; Diagnostic Errors ; Female ; Humans ; Incidence ; Medically Underserved Area ; Pelvic Inflammatory Disease/diagnosis ; Pelvic Inflammatory Disease/epidemiology ; Primary Health Care ; Retrospective Studies ; Young Adult
    Language English
    Publishing date 2011-03-28
    Publishing country Australia
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 186082-3
    ISSN 1326-5377 ; 0025-729X
    ISSN (online) 1326-5377
    ISSN 0025-729X
    DOI 10.5694/mja11.11450
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Incidence of curable sexually transmissible infections among adolescents and young adults in remote Australian Aboriginal communities: analysis of longitudinal clinical service data.

    Silver, Bronwyn J / Guy, Rebecca J / Wand, Handan / Ward, James / Rumbold, Alice R / Fairley, Christopher K / Donovan, Basil / Maher, Lisa / Dyda, Amalie / Garton, Linda / Hengel, Belinda / Knox, Janet / McGregor, Skye / Taylor-Thomson, Debbie / Kaldor, John M

    Sexually transmitted infections

    2015  Volume 91, Issue 2, Page(s) 135–141

    Abstract: Objectives: To undertake the first comprehensive analysis of the incidence of three curable sexually transmissible infections (STIs) within remote Australian Aboriginal populations and provide a basis for developing new control initiatives.: Methods: ...

    Abstract Objectives: To undertake the first comprehensive analysis of the incidence of three curable sexually transmissible infections (STIs) within remote Australian Aboriginal populations and provide a basis for developing new control initiatives.
    Methods: We obtained all results for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Trichomonas vaginalis (TV) testing conducted during 2009-2011 in individuals aged ≥16 years attending 65 primary health services across central and northern Australia. Baseline prevalence and incidence of all three infections was calculated by sex and age group.
    Results: A total of 17 849 individuals were tested over 35 months. Baseline prevalence was 11.1%, 9.5% and 17.6% for CT, NG and TV, respectively. During the study period, 7171, 7439 and 4946 initially negative individuals had a repeat test for CT, NG and TV, respectively; these were followed for 6852, 6981 and 6621 person-years and 651 CT, 609 NG and 486 TV incident cases were detected. Incidence of all three STIs was highest in 16-year-olds to 19-year-olds compared with 35+ year olds (incident rate ratio: CT 10.9; NG 11.9; TV 2.5). In the youngest age group there were 23.4 new CT infections per 100 person-years for men and 29.2 for women; and 26.1 and 23.4 new NG infections per 100 person-years in men and women, respectively. TV incidence in this age group for women was also high, at 19.8 per 100 person-years but was much lower in men at 3.6 per 100 person-years.
    Conclusions: This study, the largest ever reported on the age and sex specific incidence of any one of these three curable infections, has identified extremely high rates of new infection in young people. Sexual health is a priority for remote communities, but will clearly need new approaches, at least intensification of existing approaches, if a reduction in rates is to be achieved.
    MeSH term(s) Adolescent ; Adult ; Age Factors ; Australia/epidemiology ; Chlamydia Infections/epidemiology ; Chlamydia trachomatis/isolation & purification ; Cohort Studies ; Female ; Gonorrhea/epidemiology ; Humans ; Incidence ; Male ; Middle Aged ; Neisseria gonorrhoeae/isolation & purification ; Oceanic Ancestry Group ; Prevalence ; Retrospective Studies ; Rural Population ; Sex Factors ; Trichomonas Infections/epidemiology ; Trichomonas vaginalis/isolation & purification ; Young Adult
    Language English
    Publishing date 2015-03
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1420303-0
    ISSN 1472-3263 ; 1368-4973
    ISSN (online) 1472-3263
    ISSN 1368-4973
    DOI 10.1136/sextrans-2014-051617
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: STI in remote communities: improved and enhanced primary health care (STRIVE) study protocol: a cluster randomised controlled trial comparing 'usual practice' STI care to enhanced care in remote primary health care services in Australia.

    Ward, James / McGregor, Skye / Guy, Rebecca J / Rumbold, Alice R / Garton, Linda / Silver, Bronwyn J / Taylor-Thomson, Debbie / Hengel, Belinda / Knox, Janet / Dyda, Amalie / Law, Matthew G / Wand, Handan / Donovan, Basil / Fairley, Christopher K / Skov, Steven / Ah Chee, Donna / Boffa, John / Glance, David / McDermott, Robyn /
    Maher, Lisa / Kaldor, John M

    BMC infectious diseases

    2013  Volume 13, Page(s) 425

    Abstract: Background: Despite two decades of interventions, rates of sexually transmissible infections (STI) in remote Australian Aboriginal communities remain unacceptably high. Routine notifications data from 2011 indicate rates of chlamydia and gonorrhoea ... ...

    Abstract Background: Despite two decades of interventions, rates of sexually transmissible infections (STI) in remote Australian Aboriginal communities remain unacceptably high. Routine notifications data from 2011 indicate rates of chlamydia and gonorrhoea among Aboriginal people in remote settings were 8 and 61 times higher respectively than in the non-Indigenous population.
    Methods/design: STRIVE is a stepped-wedge cluster randomised trial designed to compare a sexual health quality improvement program (SHQIP) to usual STI clinical care delivered in remote primary health care services. The SHQIP is a multifaceted intervention comprising annual assessments of sexual health service delivery, implementation of a sexual health action plan, six-monthly clinical service activity data reports, regular feedback meetings with a regional coordinator, training and financial incentive payments. The trial clusters comprise either a single community or several communities grouped together based on geographic proximity and cultural ties. The primary outcomes are: prevalence of chlamydia, gonorrhoea and trichomonas in Aboriginal residents aged 16-34 years, and performance in clinical management of STIs based on best practice indicators. STRIVE will be conducted over five years comprising one and a half years of trial initiation and community consultation, three years of trial conditions, and a half year of data analysis. The trial was initiated in 68 remote Aboriginal health services in the Northern Territory, Queensland and Western Australia.
    Discussion: STRIVE is the first cluster randomised trial in STI care in remote Aboriginal health services. The trial will provide evidence to inform future culturally appropriate STI clinical care and control strategies in communities with high STI rates.
    Trial registration: Australian and New Zealand Clinical Trials Registry ACTRN12610000358044.
    MeSH term(s) Adolescent ; Adult ; Australia ; Female ; Humans ; Male ; Primary Health Care/standards ; Program Evaluation ; Research Design ; Rural Health/standards ; Sexually Transmitted Diseases/drug therapy ; Sexually Transmitted Diseases/epidemiology ; Young Adult
    Language English
    Publishing date 2013-09-09
    Publishing country England
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ISSN 1471-2334
    ISSN (online) 1471-2334
    DOI 10.1186/1471-2334-13-425
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top